This inventor holds 1 USPTO granted patent. Top assignee: Alza Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Kristen M Hjortsvang: Innovator in Liposome Technology
Introduction
Kristen M Hjortsvang is a notable inventor based in Fremont, CA (US). She has made significant contributions to the field of medical technology, particularly in the development of liposome compositions for radiosensitizer administration. Her innovative work aims to enhance the effectiveness of cancer treatments.
Latest Patents
Kristen holds a patent for a "Liposome composition and method for administration of a radiosensitizer." This patent describes a method for administering a radiosensitizer to a tumor site in a subject. The method involves preparing liposomes composed of a vesicle-forming lipid and a lipid-derivatized radiosensitizer. In one embodiment, the radiosensitizer is dipalmitoyl-5-iodo-2′-deoxyuridine. The patent also discloses a method for preparing the liposome composition that includes the lipid-derivatized radiosensitizer. She has 1 patent to her name.
Career Highlights
Kristen is currently associated with Alza Corporation, where she continues to work on innovative solutions in drug delivery systems. Her research focuses on improving the efficacy of cancer therapies through advanced liposome technology.
Collaborations
Some of her notable coworkers include Paul S Uster and Adam A Zetter, who have collaborated with her on various projects within the company.
Conclusion
Kristen M Hjortsvang's contributions to liposome technology represent a significant advancement in the field of cancer treatment. Her innovative methods and dedication to research continue to pave the way for improved therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile